ZimVie_Logo.png
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
May 03, 2023 16:05 ET | ZimVie Inc.
Third Party Net Sales of $225.1 million Net Loss of ($30.0) million; Net Loss Margin of (13.3%); Adjusted Net Income[1] of $6.7 millionDiluted EPS of ($1.14); Adjusted Diluted EPS[1] of $0.25Adjusted...
ZimVie_Logo.png
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
April 27, 2023 08:30 ET | ZimVie Inc.
WESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new,...
ZimVie_Logo.png
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
April 13, 2023 08:30 ET | ZimVie Inc.
WESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions...
ZimVie_Logo.png
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
April 12, 2023 16:10 ET | ZimVie Inc.
WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...
ZimVie_Logo.png
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
April 03, 2023 09:00 ET | ZimVie Inc.
WESTMINSTER, Colo., April 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the French Republic has...
ZimVie_Logo.png
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
March 23, 2023 08:30 ET | ZimVie Inc.
WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the publication of an article titled...
ZimVie_Logo.png
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
March 15, 2023 08:30 ET | ZimVie Inc.
WESTMINSTER, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that Highmark, one of America's...
ZimVie_Logo.png
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
March 01, 2023 16:05 ET | ZimVie Inc.
FY 2022 Third Party Net Sales of $909.5 million FY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%); Adjusted Net Income[1] of $47.9 millionFY 2022 Diluted EPS of ($2.45); Adjusted Diluted...
ZimVie_Logo.png
ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules
February 23, 2023 08:30 ET | ZimVie Inc.
WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE™ CAD and...
ZimVie_Logo.png
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
February 13, 2023 16:10 ET | ZimVie Inc.
WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...